You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Details for Patent: 6,943,166

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,943,166

Title:	Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
Abstract:	The present invention relates to highly selective phosphodieterase (PDE) enzyme inhibitors and to their use in pharmaceutical articles of manufacture. In particular, the present invention relates to potent inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase type 5 (PDE5) that when incorporated into a pharmaceutical product at about 1 to about 20 mg unit dosage are useful for the treatment of sexual dysfunction.
Inventor(s):	Pullman; William Ernest (Far Hills, NJ), Whitaker; John Steven (Woodinville, WA)
Assignee:	Lilly ICOS LLC. (Wilmington, DE)
Application Number:	10/031,556
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,943,166
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 6,943,166

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,943,166

PCT Information
PCT Filed	April 26, 2000	PCT Application Number:	PCT/US00/11129
PCT Publication Date:	November 09, 2000	PCT Publication Number:	WO00/66099

International Family Members for US Patent 6,943,166

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	251908	⤷ Try a Trial
Australia	2004201988	⤷ Try a Trial
Australia	3012900	⤷ Try a Trial
Australia	4490800	⤷ Try a Trial
Australia	5361201	⤷ Try a Trial
Australia	769946	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.